IBM’s Bounce Masks a Deeper Question: Are Those Deals Really Just Delayed?
Published on 07/25/2026 at 06:31 | Redaktion boerse-global.de
A single-day gain of 3.74% would normally signal a turn in sentiment. For IBM, Friday’s pop to €188.38 was less a celebration and more a gasp for air after the worst single-session rout in the company’s 114-year history. The stock had plunged 25% in one day on preliminary second-quarter figures — eclipsing even the 23.7% crash of Black Monday in 1987 — before the full numbers confirmed what traders already feared: revenue growth of just 1%, and a full-year forecast slashed from at least 5% to a range of 4% to 5% in constant currency.
CEO Arvind Krishna was unusually blunt about the miss. “What happened was worse than our expectations. We did not adapt quickly enough,” he told analysts. Yet the stock’s subsequent drift near multi-month lows, followed by Friday’s technical bounce, suggests the market had already priced in much of the damage. The relative strength index had sunk to 35.4, deep in oversold territory, and the 30-day decline of nearly 19% left ample room for a countermove.
The Mainframe Wreck That Explains Everything
The headline numbers obscure a stark internal divide. Software revenue rose 5% to $7.8 billion, with Red Hat’s hybrid cloud business climbing 11% and the data segment surging 19%. Recurring annual revenue hit $24.6 billion, up 8%. But the infrastructure division — IBM’s traditional backbone — collapsed 7% to $3.8 billion. Within that, the flagship mainframe business, IBM Z, cratered 42%, while distributed infrastructure posted a record 37% gain and left a $500 million order backlog.
CFO James Kavanaugh pinned the blame squarely on the mainframe cycle, estimating it knocked more than five percentage points off growth — far more than the company had anticipated. That mechanical explanation matters: the plunge in mainframe revenue is not a sign of permanent demand destruction but a timing mismatch in the product cycle, compounded by an industry-wide memory-chip shortage that has pushed enterprise customers toward AI hardware at the expense of legacy systems.
Should investors sell immediately? Or is it worth buying IBM?
Krishna insists the damage is temporary. He calls it “deferral, not destruction,” noting that roughly one-third of the delayed deals were already closed early in the third quarter. The critical question for investors is whether the remaining contracts will follow — or whether customers are permanently reallocating software and infrastructure budgets toward AI servers, storage, and chips.
Cash Flow Holds the Line
One number gives the bulls a genuine anchor. Free cash flow held steady at $4.8 billion in the first half, matching the prior year, and management reaffirmed its target of roughly $1 billion in growth for the full year. A $700 million improvement in adjusted EBITDA offset higher inventory, tax payments, and interest expenses. That cash-flow stability is the single strongest argument that the business is not structurally broken — just caught in a painful transition.
Yet the balance sheet has thinned. IBM ended the second quarter with $8.2 billion in cash and liquid securities, down $6.3 billion from year-end 2025, partly due to ongoing acquisitions. The annualized 30-day volatility sits at nearly 85%, reflecting a market that is pricing a wide range of outcomes rather than a clear recovery.
Two Paths, One Variable
The stock now trades 17.6% below its 50-day moving average of €228.64 and nearly 20% below the 200-day average of €233.84. The average analyst price target of €231.11 implies upside of roughly 22.7% — but that target was set before the full guidance cut and is likely to be revised lower in coming days.
IBM at a turning point? This analysis reveals what investors need to know now.
Chart watchers see two scenarios. If the deferred deals materialize in the third quarter as Krishna expects, supported by the reaffirmed cash-flow target, a gradual grind toward the 200-day average is plausible. If software or infrastructure orders slip further, a retest of the year’s low near €175 becomes the baseline risk.
The next concrete checkpoint is the third-quarter earnings report, expected in the fourth quarter of 2026. That will show whether the newly lowered growth forecast of 4% to 5% holds — or whether IBM will have to cut guidance again. Until then, Friday’s bounce looks like what it is: a technically justified relief rally in a stock that has been beaten down, not the beginning of a sustained recovery. The real test is whether those delayed deals were truly delayed — or lost for good.
Ad
IBM Stock: New Analysis - 25 July
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
